ArticleJournal of oral biology and craniofacial research
Ovine bone graft enhances osteogenic commitment in human osteoblasts via selective suppression of miR-6797-5p: In silico and in vitro study.
Article in Journal of oral biology and craniofacial research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Xenogeneic grafts are widely employed in oral and maxillofacial rehabilitation, but their biological influence extends beyond osteoconduction. Central to osteoblast differentiation is the transcription factor RUNX2, which is tightly regulated by networks of microRNAs (miRNAs). While the osteogenic effects of bovine and porcine grafts have been well studied, little is known about whether ovine bone grafts can alter RUNX2-related post-transcriptional regulation. This study aimed to investigate whether ovine bone graft-derived soluble factors modulate RUNX2-associated miRNAs and thereby influence osteogenic commitment in human osteoblast-lineage cells. Methods: Hydroxyapatite was isolated from ovine femoral bone and used to prepare conditioned medium (OBG-CM). Human osteoblastic cells and mesenchymal stem cells were exposed to OBG-CM for 24 h. Candidate RUNX2-targeting miRNAs were first identified in silico using miRDB and STarMir, with overlapping predictions screened by qRT-PCR. Predicted binding was further analysed by TargetScan. Functional assays were carried out by transfecting cells with hsa-miR-6797-5p mimics and inhibitors, followed by assessment of RUNX2 mRNA and protein expression. Results: Computational analysis highlighted several high-confidence RUNX2-targeting miRNAs, including hsa-miR-6797-5p. Exposure to OBG-CM selectively reduced the expression of hsa-miR-6797-5p, hsa-miR-889-5p and hsa-miR-122-5p, while other candidates showed minimal change. TargetScan identified a conserved 8-mer seed match for hsa-miR-6797-5p within the RUNX2 3'UTR. Transfection with the mimic suppressed RUNX2 expression at both transcript and protein levels, whereas inhibition produced the opposite effect. Conclusions: Ovine bone graft-derived factors can selectively remodel the miRNA landscape in osteoblast-lineage cells. These insights may guide the development of bioactive grafts optimised for post-transcriptional regulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.